Reduced intensity reinduction followed by blinatumomab achieves excellent MRD clearance with reduced toxicity and facilitates timely transplant in children and young people with relapsed B-precursor acute lymphoblastic leukemia
Hodder, A. Mishra, A. K. Clesham, K. Baird, S. Bhuller, K. Bisho, I. Bonney, D. Castleton, Anna Cummins, M. Dickens, E.
Hodder, A.
Mishra, A. K.
Clesham, K.
Baird, S.
Bhuller, K.
Bisho, I.
Bonney, D.
Castleton, Anna
Cummins, M.
Dickens, E.
Citations
Altmetric:
Abstract
Authors
Hodder, A.
Mishra, A. K.
Clesham, K.
Baird, S.
Bhuller, K.
Bisho, I.
Bonney, D.
Castleton, Anna
Cummins, M.
Dickens, E.
George, L.
Ghorashian, S.
Gibson, B.
Hasley, C.
Heaney, N.
Hough, R. E.
Ingham, D.
Jigoulina, G.
Lindsay, K.
Lancaster, D.
Madni, M.
Malone, A.
Mitchell, B.
Moorman, A. V.
Moppett, J.
McLelland, V.
Motwani, J.
Nicholson, E.
Osborne, C.
Patrick, K.
Samrin, L.
Tewari, S.
Thakur, I. R.
Samarasinghe, S.
Vora, A.
O'Connor, D.
Mishra, A. K.
Clesham, K.
Baird, S.
Bhuller, K.
Bisho, I.
Bonney, D.
Castleton, Anna
Cummins, M.
Dickens, E.
George, L.
Ghorashian, S.
Gibson, B.
Hasley, C.
Heaney, N.
Hough, R. E.
Ingham, D.
Jigoulina, G.
Lindsay, K.
Lancaster, D.
Madni, M.
Malone, A.
Mitchell, B.
Moorman, A. V.
Moppett, J.
McLelland, V.
Motwani, J.
Nicholson, E.
Osborne, C.
Patrick, K.
Samrin, L.
Tewari, S.
Thakur, I. R.
Samarasinghe, S.
Vora, A.
O'Connor, D.
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Hodder A, Mishra AK, Clesham K, Baird S, Bhuller K, Bisho I, et al. Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia. Blood. 2022 Nov;140:3268-70. PubMed PMID: WOS:000893223203136.